These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3278917)

  • 21. Mechanisms responsible for coronary vasospasm.
    Shepherd JT; Vanhoutte PM
    J Am Coll Cardiol; 1986 Jul; 8(1 Suppl A):50A-54A. PubMed ID: 3519733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelets, endothelium, and vasospasm.
    Vanhoutte PM; Houston DS
    Circulation; 1985 Oct; 72(4):728-34. PubMed ID: 3861273
    [No Abstract]   [Full Text] [Related]  

  • 23. How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevance.
    Golino P; Crea F; Willerson JT
    Ital Heart J; 2002 Apr; 3(4):220-5. PubMed ID: 12025369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin, hypertension and vascular disease.
    Vanhoutte PM
    Neth J Med; 1991 Feb; 38(1-2):35-42. PubMed ID: 2030808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender differences and endothelium- and platelet-derived factors in the coronary circulation.
    Miller VM; Lewis DA; Barber DA
    Clin Exp Pharmacol Physiol; 1999 Feb; 26(2):132-6. PubMed ID: 10065334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries.
    Pearson PJ; Schaff HV; Vanhoutte PM
    Circulation; 1990 Jun; 81(6):1921-7. PubMed ID: 2344684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte and platelet-derived factors augment canine coronary constriction to serotonin.
    Cappelli-Bigazzi M; Lamping KG; Nuno DW; Harrison DG
    Am J Physiol; 1990 Oct; 259(4 Pt 2):H1161-70. PubMed ID: 2171364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endothelial dysfunction and coronary heart disease. Interaction of endothelium and thrombocytes].
    Vanhoutte PM
    Schweiz Rundsch Med Prax; 1993 Oct; 82(42):1161-6. PubMed ID: 8248687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-derived serotonin, the endothelium, and cardiovascular disease.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S6-12. PubMed ID: 1717775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypercholesterolaemia, atherosclerosis and release of endothelium-derived relaxing factor by aggregating platelets.
    Vanhoutte PM
    Eur Heart J; 1991 Nov; 12 Suppl E():25-32. PubMed ID: 1790781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intact endothelium against platelet-induced coronary artery spasm in isolated rabbit hearts.
    Bing RJ; Burger W; Chemnitius JM; Saeed M; Metz MZ
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1596-600. PubMed ID: 4003303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different interactions of platelets with arterial and venous coronary bypass vessels.
    Yang ZH; Stulz P; von Segesser L; Bauer E; Turina M; Lüscher TF
    Lancet; 1991 Apr; 337(8747):939-43. PubMed ID: 1678031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries.
    Shimokawa H; Vanhoutte PM
    Circulation; 1988 Dec; 78(6):1421-30. PubMed ID: 3191596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of PAF (platelet-activating factor) on hemostasis. Studies on endothelial cells and platelets].
    Rotllan E; Escolar G; Ordinas A; Bastida E
    Sangre (Barc); 1993 Apr; 38(2):115-9. PubMed ID: 8390724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of coronary vasospasm: role of endothelium.
    Shepherd JT; Katusic ZS; Vedernikov Y; Vanhoutte PM
    J Mol Cell Cardiol; 1991 Feb; 23 Suppl 1():125-31. PubMed ID: 2038073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The endothelium, platelets, and coronary vasospasm.
    Hoak JC
    Adv Intern Med; 1989; 34():353-75. PubMed ID: 2644764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review.
    De Clerck F; van Nueten JM; Reneman RS
    Agents Actions; 1984 Dec; 15(5-6):612-26. PubMed ID: 6397984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origin, metabolism and function of extracellular adenine nucleotides in the blood.
    Lüthje J
    Klin Wochenschr; 1989 Mar; 67(6):317-27. PubMed ID: 2651791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet interactions with the vessel wall and prosthetic grafts.
    Rubin BG; Santoro SA; Sicard GA
    Ann Vasc Surg; 1993 Mar; 7(2):200-7. PubMed ID: 8518140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of vascular smooth muscle contraction by the endothelium.
    Vanhoutte PM; Rubanyi GM; Miller VM; Houston DS
    Annu Rev Physiol; 1986; 48():307-20. PubMed ID: 2871807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.